News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Avicenna Biosciences and Molecure S.A. Form Strategic Collaboration to Boost Small Molecule Drug Development
Thursday, August 01, 2024Molecure SA and Avicenna Biosciences Inc have announced a strategic research partnership to develop novel small molecule drugs targeting ubiquitinspecific protease a deubiquitinase linked
Halia Therapeutics and Biolexis Therapeutics Announce Key Breakthrough in Neuroinflammation Research
Thursday, August 01, 2024Halia Therapeutics a biopharmaceutical company focused on novel small molecule therapies for inflammation and Biolexis Therapeutics known for its AIdriven drug discovery have announced a significant advancement in their collaboration
Leveragen Forms Collaboration with Moderna to Enhance Therapeutics Using Unique Fully Human Single Domain Antibody Technology
Wednesday, July 31, 2024Leveragen Inc a Bostonbased biotech startup has announced a new multitarget research option and license agreement with Moderna Inc Leveragen will use its proprietary single domain antibody discovery
Verseon and NeuTherX Partner to Boost Drug Development Efforts
Wednesday, July 31, 2024Verseon and NeuTherX are thrilled to announce a new partnership designed to enhance drug development through NeuTherXs advanced organoid cultivation technology Verseon is committed to refining the drug development process focusing on creating treatme...
Boehringer Ingelheim Expands Portfolio with Acquisition of Nerio Therapeutics' Immune Checkpoint Inhibitor
Tuesday, July 30, 2024Boehringer Ingelheim has made a major advancement in its immunooncology pipeline by acquiring Nerio Therapeutics Inc for up to USD billion This acquisition
Inductive Bio Announces Successful Outcomes from Drug Optimization Collaboration with Nested Therapeutics
Tuesday, July 30, 2024Inductive Bio a pioneer in utilizing machine learning ML to advance small molecule drug discovery has shared new insights from their recent collaboration with Nested Therapeutics Nested recognized
European Medicines Agency’s CHMP Issues Favorable Opinion for GSK’s Arexvy Vaccine for Adults Aged 50-59 at Higher Risk of RSV
Monday, July 29, 2024GSK plc has revealed that the European Medicines Agencys Committee for Medicinal Products for Human Use CHMP has recommended broadening the approval of GSKs RSV vaccine
Presage Biosciences Starts Initial Patient Dosing of Pure Biologics' Antibody Targeting ROR1 for Cancer Therapy
Friday, July 26, 2024Presage Biosciences known for its expertise in evaluating oncology drugs within human tumors has initiated Phase dosing with PBA an antibody from Pure Biologics that targets ROR
Kashiv BioSciences Concludes Patient Enrollment for Phase III Study of ADL018, a Biosimilar to XOLAIR® (omalizumab)
Friday, July 26, 2024Kashiv BioSciences LLC has completed patient enrollment for its Phase III clinical trial of ADL a biosimilar candidate to XOLAIR This pivotal trial is designed to assess how ADL compares to XOLAIR
Dren Bio and Novartis Forge Collaboration to Develop Innovative Targeted Myeloid Engagers for Cancer Treatment
Thursday, July 25, 2024Dren Bio Inc a private clinicalstage biopharmaceutical company has announced a strategic collaboration with Novartis Pharma AG a subsidiary of Novartis AG This partnership aims to advance the discovery
